Dr. Iman Naseri, MD

Dr. Naseri practices at North Florida Surgeons, PA in Jacksonville, Florida.

Dr. Naseri's NPI, 1700060555, was assigned on December 27, 2007. Dr. Naseri graduated from Medical University of South Carolina (MUSC) in 2003. Dr. Naseri holds Florida license ME105498.

Dr. Naseri's primary practice is North Florida Surgeons, PA, at 2 Shircliff Way, Jacksonville, FL 32204 in Duval County. The practice phone is (904) 396-1725.

Dr. Naseri's primary practice is North Florida Surgeons, PA in Jacksonville, Florida. Dr. Naseri is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is North Florida Surgeons. Dmand AI also links Dr. Naseri to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Naseri practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Naseri's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Naseri is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Naseri's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Naseri treats.

CMS data shows 914 Medicare services from Dr. Naseri across 14 procedure codes in 2024, for 254 Medicare patients. Medicare paid $114,869 for them.

CMS counts 254 Medicare patients who saw Dr. Naseri in 2024. The largest group is 65 to 74, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Naseri's median patient age at 65, with 51% women.

In 2024, Dr. Naseri wrote 902 Medicare Part D claims for 255 patients. 91% of them were for generic drugs. CMS names the drug for 723 of them, across 28 drugs with 11 or more claims each, at $63,282 in total drug cost. In 2023, CMS named 559 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Naseri for performance year 2024, reported as part of a group. Dr. Naseri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Naseri, published from 2015 to 2018. The most frequent topics are Anti-Infective Agents, Head and Methicillin Resistance. Dr. Naseri has published most often in J Neurol Surg Rep. Dr. Naseri's most frequent co-authors are Steven Sobol, MD, Philipp Roque Aldana, MD and Vincent Anagnos, DO.

CMS Open Payments shows 95 general payments to Dr. Naseri from 15 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 46% of the total. Medtronic USA, Inc. paid the most, $30,055. It also lists 1 research payment totaling $1,092 in 2016.

Dmand AI lists 4 awards for Dr. Naseri. Dr. Naseri serves on The Florida Society of Otolaryngology.

Dr. Naseri graduated from Medical University of South Carolina (MUSC) in 2003. Dr. Naseri is a member of NHS and ACS.